NYSE:TDOC - Teladoc Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$58.77 -4.49 (-7.10 %)
(As of 03/24/2019 04:00 PM ET)
Previous Close$58.77
Today's Range$58.69 - $63.3544
52-Week Range$38.15 - $89.05
Volume1.70 million shs
Average Volume1.75 million shs
Market Capitalization$4.16 billion
P/E Ratio-40.81
Dividend YieldN/A
Beta1.44
Teladoc Health, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone203-635-2002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.91 million
Book Value$14.45 per share

Profitability

Net Income$-97,080,000.00

Miscellaneous

Employees2,000
Market Cap$4.16 billion
Next Earnings Date5/7/2019 (Estimated)
OptionableOptionable

Teladoc Health (NYSE:TDOC) Frequently Asked Questions

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc Health's earnings last quarter?

Teladoc Health Inc (NYSE:TDOC) posted its quarterly earnings results on Tuesday, May, 1st. The health services provider reported ($0.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.04. The health services provider had revenue of $89.64 million for the quarter, compared to analyst estimates of $86.77 million. Teladoc Health had a negative net margin of 23.23% and a negative return on equity of 11.59%. The company's quarterly revenue was up 109.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.30) earnings per share. View Teladoc Health's Earnings History.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for Teladoc Health.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its first quarter earnings guidance on Wednesday, February, 27th. The company provided EPS guidance of (0.46)-(0.44) for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.30). The company issued revenue guidance of $126-129 million, compared to the consensus revenue estimate of $131.13 million.Teladoc Health also updated its FY 2019 guidance to $-1.66--1.52 EPS.

What price target have analysts set for TDOC?

17 brokerages have issued 1 year target prices for Teladoc Health's shares. Their predictions range from $56.00 to $100.00. On average, they expect Teladoc Health's stock price to reach $83.0588 in the next year. This suggests a possible upside of 41.3% from the stock's current price. View Analyst Price Targets for Teladoc Health.

What is the consensus analysts' recommendation for Teladoc Health?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teladoc Health.

What are Wall Street analysts saying about Teladoc Health stock?

Here are some recent quotes from research analysts about Teladoc Health stock:
  • 1. According to Zacks Investment Research, "Teladoc’s shares have outperformed its industry in a year's time. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. It is witnessing growth in its client roster due to the addition of new clients across multiple market segments. Teladoc is witnessing an increase in revenues driven by a rise membership and visits. Its sturdy 2019 guidance should instill investors’ confidence in the stock. However, it has incurred significant losses and has been unable to generate cash from operations. Its struggles may continue in the coming quarters too. Its high debt level caused a spike in interest expenses, which weighs on operating margins." (3/15/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on TDOC shares and lower our 12-month price target to $70 from $83. After the close on Wednesday, Feb. 27, TDOC reported 4Q18 results. Revenue and adjusted EBITDA were slightly above our estimate and FactSet consensus. TDOC provided its initial 2019 guidance, which was below our estimates and consensus. We continue to believe that TDOC is positioned to benefit from increasing virtual health adoption. However, the shares’ current valuation, relative to our revised price target, keeps us on the sidelines." (2/27/2019)

Has Teladoc Health been receiving favorable news coverage?

Media coverage about TDOC stock has trended neutral this week, InfoTrie reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teladoc Health earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news headlines about the health services provider a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an impact on the stock's share price in the next few days.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Square (SQ), Netflix (NFLX), Micron Technology (MU), Shopify (SHOP), Twilio (TWLO), salesforce.com (CRM), Advanced Micro Devices (AMD) and Adobe (ADBE).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the folowing people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 47)
  • Mr. Peter A. McClennen, Pres & Interim COO (Age 50)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 44)
  • Dr. Lewis Levy M.D., FACP, Chief Medical Officer (Age 60)
  • Dr. George Byron Brooks BS EE, M.D., Co-Founder

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (1.75%), Macquarie Group Ltd. (1.61%), Bellevue Group AG (1.53%), Eagle Asset Management Inc. (1.45%), Bank of New York Mellon Corp (1.40%) and Northern Trust Corp (1.31%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Michael H King, Michelle Bucaria, Peter A Mcclennen and Stephany Verstraete. View Institutional Ownership Trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Jennison Associates LLC, IFP Advisors Inc, Oppenheimer & Co. Inc., KBC Group NV, First Trust Advisors LP, TD Asset Management Inc. and Triodos Investment Management BV. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen and Stephany Verstraete. View Insider Buying and Selling for Teladoc Health.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Macquarie Group Ltd., Bellevue Group AG, Bank of New York Mellon Corp, Riverbridge Partners LLC, Sectoral Asset Management Inc, Emerald Advisers LLC and Fiera Capital Corp. View Insider Buying and Selling for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $58.77.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $4.16 billion and generates $417.91 million in revenue each year. The health services provider earns $-97,080,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. Teladoc Health employs 2,000 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is http://www.teladoc.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]


MarketBeat Community Rating for Teladoc Health (NYSE TDOC)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  437 (Vote Outperform)
Underperform Votes:  279 (Vote Underperform)
Total Votes:  716
MarketBeat's community ratings are surveys of what our community members think about Teladoc Health and other stocks. Vote "Outperform" if you believe TDOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel